BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20817 |
Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20810 |
Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20811 |
Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20812 |
Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20813 |
Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20814 |
Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20815 |
Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20816 |
Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20818 |
Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20819 |
Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20820 |
Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR2087 |
Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR2088 |
Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR2089 |
Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20821 Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20821 |
Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20822 Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20822 |
Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20823 Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20823 |
Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20824 Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20824 |
Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20825 Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20825 |
Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20826 Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20826 |
Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20827 Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20827 |
Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20828 Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20828 |
Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20829 Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20829 |
Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20830 Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20830 |
Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20831 Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20831 |
Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO2086 |
Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC2087 |
Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO20810 |
Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO2087 |
Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO2088 |
Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CO2089 |
Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2084 |
Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2085 |
Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
ENS2081 |
Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2085 |
Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2086 |
Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2087 |
Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2088 |
Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC20810 |
Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC20811 |
Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC2088 |
Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LC2089 |
Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 516 |
LV2084 |
Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
516€ |
|
Pub |
LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2085 |
Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2086 |
Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2087 |
Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
LV2088 |
Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2085 Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2085 |
Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2086 Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2086 |
Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2087 Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2087 |
Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2088 Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2088 |
Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2089 Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
OV2089 |
Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BR1007 |
Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR20832 Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
BR20832 |
Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20833 Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
BR20833 |
Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20834 Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
BR20834 |
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20835 Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
BR20835 |
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20836 Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
BR20836 |
Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456 |
BR2086 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 |
US Biomax |
|
456€ |
|
Pub |
GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed US Biomax 487 |
GL2083a |
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
487€ |
|
Pub |
MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores US Biomax 456 |
MC2082 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397 |
BC001134 |
Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores |
US Biomax |
|
397€ |
|
Pub |
BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed US Biomax 258 |
BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BL1001 |
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296 |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- US Biomax 296 |
BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- |
US Biomax |
|
296€ |
|
Pub |
BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin US Biomax 296 |
BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin |
US Biomax |
|
296€ |
|
Pub |
BR1922 Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
BR1922 |
Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed US Biomax 90 |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed US Biomax 90 |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246 US Biomax 88 |
BR245 |
Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246 |
US Biomax |
|
88€ |
|
Pub |
BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a US Biomax 88 |
BR246 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a |
US Biomax |
|
88€ |
|
Pub |
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231 |
BR8014 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 |
US Biomax |
|
231€ |
|
Pub |
BR8016 Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 |
BR8016 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BR8017 Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 |
BR8017 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258 |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267 |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296 |
BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
BR964 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed US Biomax 258 |
BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
CO1922 |
Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
CO20811 Colon tumor survey tissue array (1 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
CO20811 |
Colon tumor survey tissue array (1 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO20812 Colon tumor survey tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
CO20812 |
Colon tumor survey tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO20813 Colon tumor survey tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
CO20813 |
Colon tumor survey tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO20814 Colon tumor survey tissue array (4 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
CO20814 |
Colon tumor survey tissue array (4 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR2083 Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2083 |
Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR2086 Cervix tumor tissue array (4 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2086 |
Cervix tumor tissue array (4 of 5), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR2087 Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
CR2087 |
Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
ES1001 |
Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed US Biomax 267 |
FDA808a-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266 |
HN811 |
Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 |
US Biomax |
|
266€ |
|
Pub |
KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
KD1001 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
KD2089 Kidney cancer survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 |
KD2089 |
Kidney cancer survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
KD961 |
Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
LC1009 |
Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LV1921 Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
LV1921 |
Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed US Biomax 429 |
LV2091 |
Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed |
US Biomax |
|
429€ |
|
Pub |
MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed US Biomax 90 |
MC246 |
Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores US Biomax 231 |
MC485 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 US Biomax 266 |
MC964 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 |
US Biomax |
|
266€ |
|
Pub |
MCN602 Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 US Biomax 231 |
MCN602 |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 |
US Biomax |
|
231€ |
|
Pub |
OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
OV1003 |
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
OV1921 Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
OV1921 |
Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
OV961 |
Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
SK961 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90 |
T032a |
Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T081 Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 US Biomax 88 |
T081 |
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 |
US Biomax |
|
88€ |
|
Pub |
T083 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T083 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T085 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 US Biomax 88 |
T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 |
US Biomax |
|
88€ |
|
Pub |
T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90 |
T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90 |
T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T089 Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T089 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90 |
T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T214 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T271 Oral cavity tumor test tissue array, with normal oral cavity control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T271 |
Oral cavity tumor test tissue array, with normal oral cavity control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T301 Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T301 |
Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T321 Spleen tumor test tissue array, with normal spleen control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T321 |
Spleen tumor test tissue array, with normal spleen control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
UT1001 Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
UT1001 |
Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BC000119 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 |
BC000119 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC000120 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 |
BC000120 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC001130 Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores US Biomax 278 |
BC001130 |
Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores |
US Biomax |
|
278€ |
|
Pub |
BC01001 Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores US Biomax 231 |
BC01001 |
Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores |
US Biomax |
|
231€ |
|
Pub |
BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185 |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BC01114 Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases 100 cores US Biomax 231 |
BC01114 |
Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266 |
BC03002 |
Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores US Biomax 231 |
BC03116 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores |
US Biomax |
|
231€ |
|
Pub |
BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 |
BC03118 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 |
BC03119 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
278€ |
|
Pub |
BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266 |
BC04002 |
Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BC041114 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 |
BC041114 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC041115 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 |
BC041115 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
278€ |
|
Pub |
BC041115a Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed US Biomax 296 |
BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BC04118 Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b US Biomax 231 |
BC04119 |
Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b |
US Biomax |
|
231€ |
|
Pub |
BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266 |
BC05002 |
Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 |
BC051110 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
278€ |
|
Pub |
BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 |
BC051111 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC05115 Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 US Biomax 231 |
BC05115 |
Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 |
US Biomax |
|
231€ |
|
Pub |
BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 |
BC05118 |
Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed US Biomax 296 |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185 |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BC081115 Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120 US Biomax 278 |
BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120 |
US Biomax |
|
278€ |
|
Pub |
BC081116 Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores US Biomax 278 |
BC081116 |
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores |
US Biomax |
|
278€ |
|
Pub |
BC081120 Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115 US Biomax 266 |
BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115 |
US Biomax |
|
266€ |
|
Pub |
BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185 |
BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162 |
BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores US Biomax 266 |
BC19021 |
Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BL1921 Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
BL1921 |
Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
BL244 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a US Biomax 456 |
BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a |
US Biomax |
|
456€ |
|
Pub |
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314 |
BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 |
US Biomax |
|
314€ |
|
Pub |
CO1003 Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
CO1003 |
Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
CO1004 |
Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 |
CO1021 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
CO1502 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed US Biomax 105 |
CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
CO242a Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed US Biomax 81 |
CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed |
US Biomax |
|
81€ |
|
Pub |
CO243a Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed US Biomax 105 |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210 |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 |
CO485 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
CO486 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
CO488 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 |
CO488 |
Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed US Biomax 267 |
CO804a |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
CO962 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CR1002 Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
CR1002 |
Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
CR1003 |
Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
CR1501 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CR1921 Middle advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
CR1921 |
Middle advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
CR2088 Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
CR2088 |
Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR2089 Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
CR2089 |
Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR245 Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
CR245 |
Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
DGS2081 Digestive system tissue array, including TNM, stage and grade, 104 cases 208 cores US Biomax 456 |
DGS2081 |
Digestive system tissue array, including TNM, stage and grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 |
ES1002 |
Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
ES1502 |
Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
ES1921 Middle advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
ES1921 |
Middle advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
ES8012 Middle advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 278 |
ES8012 |
Middle advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
278€ |
|
Pub |
ES962 Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed US Biomax 90 |
HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90 |
HN242a |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296 |
HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
KD1002 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
KD1501 |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
KD1921 Mid advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
KD1921 |
Mid advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
KD20810 Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
KD20810 |
Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD20811 Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
KD20811 |
Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD20812 Kidney cancer survey tissue array (3 of 3), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
KD20812 |
Kidney cancer survey tissue array (3 of 3), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC10011 Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
LC10011 |
Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LC1008 Non small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
LC1008 |
Non small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC1502 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC488 Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 |
LC488 |
Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 US Biomax 231 |
LC726 |
Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 |
US Biomax |
|
231€ |
|
Pub |
LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228 |
LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC817 |
Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC961 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
LV1001 |
Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
LV1002 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LV1201 Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 397 |
LV1201 |
Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
397€ |
|
Pub |
LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
LV1502 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LV20810 Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV20810 |
Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV20811 Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV20811 |
Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2089 Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LV2089 |
Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 |
LV484 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
LV485 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
LV962 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LVN801 Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 US Biomax 231 |
LVN801 |
Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 |
US Biomax |
|
231€ |
|
Pub |
MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88 |
MC245 |
Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 |
US Biomax |
|
88€ |
|
Pub |
MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores US Biomax 516 |
MC2501 |
Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores |
US Biomax |
|
516€ |
|
Pub |
MC601 Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 |
MC601 |
Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
MC809a Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed US Biomax 382 |
MC809a |
Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed |
US Biomax |
|
382€ |
|
Pub |
MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 |
MGS801 |
Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258 |
OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
OV1004 |
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266 |
OV1005 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 |
US Biomax |
|
266€ |
|
Pub |
OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267 |
OV1005a |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
OV20810 Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20810 |
Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 US Biomax 456 |
OV2084 |
Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 |
US Biomax |
|
456€ |
|
Pub |
OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105 |
OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
OV484 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 |
OV484 |
Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
OV485 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
OV485 |
Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228 |
OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258 |
OV803a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
PA1921 Mid advanced stage pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
PA1921 |
Mid advanced stage pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105 |
PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296 |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores US Biomax 278 |
PA961 |
Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores |
US Biomax |
|
278€ |
|
Pub |
PA961a Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed US Biomax 258 |
PA961a |
Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
PR242a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed US Biomax 105 |
PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PR243a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed US Biomax 105 |
PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210 |
PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162 |
PR484 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296 |
PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296 |
PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 |
RE1021 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
RE1503 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
RE601 Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 |
RE601 |
Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
SK245 |
Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
ST1002 Stomach carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
ST1002 |
Stomach carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
ST1003 |
Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
ST1921 Middle advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
ST1921 |
Middle advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185 |
ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210 |
ST483b |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
ST962 |
Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
T012 Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T012 |
Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T013 Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T013 |
Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T014 Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T014 |
Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T022 Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T022 |
Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T023 Esophagus carcer test tissue array, with normal esophagus tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T023 |
Esophagus carcer test tissue array, with normal esophagus tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T024 Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T024 |
Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T032 Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T032 |
Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T033 Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T033 |
Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T034 Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T034 |
Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T041 Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T041 |
Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T042 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 US Biomax 88 |
T042 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 |
US Biomax |
|
88€ |
|
Pub |
T043 Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T043 |
Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T044 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 US Biomax 88 |
T044 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 |
US Biomax |
|
88€ |
|
Pub |
T045 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b US Biomax 88 |
T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b |
US Biomax |
|
88€ |
|
Pub |
T045b Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 US Biomax 99 |
T045b |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 |
US Biomax |
|
99€ |
|
Pub |
T046 Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T046 |
Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T047 Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T047 |
Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T051 Colon cancer test tissue array, with normal colon tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T051 |
Colon cancer test tissue array, with normal colon tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T052 Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T052 |
Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T053 Colon cancer test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T053 |
Colon cancer test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T054a Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed US Biomax 90 |
T054a |
Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T061 Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T061 |
Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T063 Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T063 |
Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T071 |
Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T073 Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T073 |
Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T074 Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T074 |
Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T091 Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T091 |
Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T092 Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T092 |
Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T093 Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T093 |
Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T095 Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T095 |
Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T101 Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T101 |
Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T102 Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T102 |
Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T104 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T111 Ovary cancer test tissue array, with normal ovary control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T111 |
Ovary cancer test tissue array, with normal ovary control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T112 Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T112 |
Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90 |
T112a |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T113 Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T113 |
Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T113a Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed US Biomax 90 |
T113a |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T121 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T121 |
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T122 Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T122 |
Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T123 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T123 |
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90 |
T124 |
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T125 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T141 Pancreatic cancer test tissue array, with normal pancreas control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T141 |
Pancreatic cancer test tissue array, with normal pancreas control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T142 Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T142 |
Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T143 Pancreatic cancer test tissue array, with normal pancreatic tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T143 |
Pancreatic cancer test tissue array, with normal pancreatic tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T144 |
Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T151 Thyroid cancer test tissue array, with normal thyroid control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T151 |
Thyroid cancer test tissue array, with normal thyroid control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T153 Thyroid cancer test tissue array, with normal thyroid gland tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T153 |
Thyroid cancer test tissue array, with normal thyroid gland tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T163 Nose, pharyngeal and laryngeal cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T163 |
Nose, pharyngeal and laryngeal cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T172 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T172 |
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T173 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T173 |
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T191 Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T191 |
Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T192 Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195 US Biomax 88 |
T192 |
Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195 |
US Biomax |
|
88€ |
|
Pub |
T193 Prostate cancer test tissue array, with normal prostate tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T193 |
Prostate cancer test tissue array, with normal prostate tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105 |
T195a |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
T211 Skin cancer test tissue array, with normal skin control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T211 |
Skin cancer test tissue array, with normal skin control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T212 Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T212 |
Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T221 Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T221 |
Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T223 Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T223 |
Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T231 Testis cancer test tissue array, with normal testis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T231 |
Testis cancer test tissue array, with normal testis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T241 Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T241 |
Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T261 Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T261 |
Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T273 Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T273 |
Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T342 Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T342 |
Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T343 |
Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T421 Small intestine cancer test tissue array, with normal small intestine tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T421 |
Small intestine cancer test tissue array, with normal small intestine tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T461 Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T461 |
Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
UT1501 |
Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
UT243 Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
UT243 |
Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
UT961 |
Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
BC08118 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores US Biomax 321 |
BC08118 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores |
US Biomax |
|
321€ |
|
Pub |
BL805 Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
BL805 |
Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482 US Biomax 266 |
BM483 |
Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482 |
US Biomax |
|
266€ |
|
Pub |
BR041 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a US Biomax 88 |
BR041 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a |
US Biomax |
|
88€ |
|
Pub |
BR042a Breast cancer tissue array, including TNM and pathology grade, 4 cases 4 cores US Biomax 88 |
BR042a |
Breast cancer tissue array, including TNM and pathology grade, 4 cases 4 cores |
US Biomax |
|
88€ |
|
Pub |
BR082 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores US Biomax 112 |
BR082 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores |
US Biomax |
|
112€ |
|
Pub |
BR10010 Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004 US Biomax 314 |
BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004 |
US Biomax |
|
314€ |
|
Pub |
BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme US Biomax 296 |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme |
US Biomax |
|
296€ |
|
Pub |
BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266 |
BR1003 |
Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data |
US Biomax |
|
266€ |
|
Pub |
BR1008 Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212 US Biomax 266 |
BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212 |
US Biomax |
|
266€ |
|
Pub |
BR1009 Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
BR1009 |
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR1503 Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 US Biomax 278 |
BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 |
US Biomax |
|
278€ |
|
Pub |
BR1504 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores US Biomax 266 |
BR1504 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores |
US Biomax |
|
266€ |
|
Pub |
BR2083 High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores US Biomax 456 |
BR2083 |
High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR2161 Breast cancer tissue array, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
BR2161 |
Breast cancer tissue array, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243 US Biomax 99 |
BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243 |
US Biomax |
|
99€ |
|
Pub |
BR243b Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed US Biomax 90 |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246 US Biomax 99 |
BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246 |
US Biomax |
|
99€ |
|
Pub |
BR247 Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections sllide US Biomax 189 |
BR247 |
Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections sllide |
US Biomax |
|
189€ |
|
Pub |
BR484 Breast cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 231 |
BR484 |
Breast cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
BR485 Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 |
BR485 |
Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases 96 cores |
US Biomax |
|
397€ |
|
Pub |
BR486 Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 225 |
BR486 |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
225€ |
|
Pub |
BR723 Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases 72 cores US Biomax 314 |
BR723 |
Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases 72 cores |
US Biomax |
|
314€ |
|
Pub |
BR8013 Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores US Biomax 231 |
BR8013 |
Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 US Biomax 231 |
BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 |
US Biomax |
|
231€ |
|
Pub |
BR8018 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014 US Biomax 266 |
BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014 |
US Biomax |
|
266€ |
|
Pub |
CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores US Biomax 456 |
CO2081 |
Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR806 Mid advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
CR806 |
Mid advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 US Biomax 336 |
FDA807-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 |
US Biomax |
|
336€ |
|
Pub |
FDA808-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 US Biomax 277 |
FDA808-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 |
US Biomax |
|
277€ |
|
Pub |
GL1921 Mid advanced stage brain tumor tissue array, including pathology grade, 96 cases 192 cores US Biomax 456 |
GL1921 |
Mid advanced stage brain tumor tissue array, including pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
KD808 Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 231 |
KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
KD951 Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores US Biomax 456 |
KD951 |
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores |
US Biomax |
|
456€ |
|
Pub |
LC1922 Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores US Biomax 456 |
LC1922 |
Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
LC20812 Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20812 |
Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC20813 Lung cancer tissue array (2 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20813 |
Lung cancer tissue array (2 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC20814 Lung cancer tissue array (3 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20814 |
Lung cancer tissue array (3 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC20815 Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20815 |
Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC20816 Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
LC20816 |
Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV20812 Liver tissue cancer tissue array, containing HBV infection, TNM and pathology grade information, 104 cases 208 cores US Biomax 456 |
LV20812 |
Liver tissue cancer tissue array, containing HBV infection, TNM and pathology grade information, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV486 Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 231 |
LV486 |
Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
LV8012 Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 231 |
LV8012 |
Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed US Biomax 811 |
MC6163 |
High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed |
US Biomax |
|
811€ |
|
Pub |
MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320 |
MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed |
US Biomax |
|
320€ |
|
Pub |
ME2082 Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores US Biomax 456 |
ME2082 |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429 |
ME2082a |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed |
US Biomax |
|
429€ |
|
Pub |
OV1501 Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 cores US Biomax 231 |
OV1501 |
Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 cores |
US Biomax |
|
231€ |
|
Pub |
OV20811 Ovary cancer tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20811 |
Ovary cancer tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV20812 Ovary cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20812 |
Ovary cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV20813 Ovary cancer tissue array (4 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 |
OV20813 |
Ovary cancer tissue array (4 of 4), including TNM and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV20814 Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases 208 cores, replacing OV2084 US Biomax 558 |
OV20814 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases 208 cores, replacing OV2084 |
US Biomax |
|
558€ |
|
Pub |
OV8010 Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
OV8010 |
Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
PA1003 Pancreas cancer tissue array for antibody screening, including TNM and pathology grade, 25 cases 100 cores US Biomax 314 |
PA1003 |
Pancreas cancer tissue array for antibody screening, including TNM and pathology grade, 25 cases 100 cores |
US Biomax |
|
314€ |
|
Pub |
PM2-ER ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed US Biomax 114 |
PM2-ER |
ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed |
US Biomax |
|
114€ |
|
Pub |
PR1001 Prostate cancer tissue array, including TNM and pathology grade, 25 cases 100 cores US Biomax 266 |
PR1001 |
Prostate cancer tissue array, including TNM and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
SF961 Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
SF961 |
Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487 |
ST2091 |
Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed |
US Biomax |
|
487€ |
|
Pub |
ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores US Biomax 231 |
ST812 |
Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
T001 Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores US Biomax 88 |
T001 |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90 |
T001a |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T054 Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052 US Biomax 88 |
T054 |
Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052 |
US Biomax |
|
88€ |
|
Pub |
T072 Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T072 |
Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T082 Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084 US Biomax 88 |
T082 |
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084 |
US Biomax |
|
88€ |
|
Pub |
T086 Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 US Biomax 88 |
T086 |
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 |
US Biomax |
|
88€ |
|
Pub |
T086a Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed US Biomax 90 |
T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T088 Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 US Biomax 88 |
T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 |
US Biomax |
|
88€ |
|
Pub |
T142a Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed US Biomax 90 |
T142a |
Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T174 Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171 US Biomax 88 |
T174 |
Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171 |
US Biomax |
|
88€ |
|
Pub |
T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90 |
T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T243 Soft tissue tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T243 |
Soft tissue tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T244 Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T244 |
Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T303 Heart tumor test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T303 |
Heart tumor test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
TP241 Top 4 types of cancer (colon, breast, lung and prostate) tissue array, including TNM and pathology grade, 12 cases 24 cores US Biomax 99 |
TP241 |
Top 4 types of cancer (colon, breast, lung and prostate) tissue array, including TNM and pathology grade, 12 cases 24 cores |
US Biomax |
|
99€ |
|
Pub |
BC001128 Top five cancer tissue array, including TNM and pathology grade, 148 cases 175 cores US Biomax 485 |
BC001128 |
Top five cancer tissue array, including TNM and pathology grade, 148 cases 175 cores |
US Biomax |
|
485€ |
|
Pub |
BC04119b Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 US Biomax 336 |
BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 |
US Biomax |
|
336€ |
|
Pub |
BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores US Biomax 321 |
BC06002 |
Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores |
US Biomax |
|
321€ |
|
Pub |
BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores US Biomax 321 |
BC07001 |
Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores |
US Biomax |
|
321€ |
|
Pub |
BC07114 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores US Biomax 558 |
BC07114 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores |
US Biomax |
|
558€ |
|
Pub |
BC07115 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases 120 cores US Biomax 321 |
BC07115 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases 120 cores |
US Biomax |
|
321€ |
|
Pub |
BC110118 Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012 US Biomax 231 |
BC110118 |
Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012 |
US Biomax |
|
231€ |
|
Pub |
BC111109 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231 |
BC111109 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores |
US Biomax |
|
231€ |
|
Pub |
BC111110 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231 |
BC111110 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores |
US Biomax |
|
231€ |
|
Pub |
BC11115 Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases 100 cores US Biomax 321 |
BC11115 |
Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases 100 cores |
US Biomax |
|
321€ |
|
Pub |
BCN963 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 US Biomax 266 |
BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 |
US Biomax |
|
266€ |
|
Pub |
BL1002 Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
BL1002 |
Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BL242 Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores US Biomax 189 |
BL242 |
Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
BL482 Bladder cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
BL482 |
Bladder cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
BL801 Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806 US Biomax 266 |
BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806 |
US Biomax |
|
266€ |
|
Pub |
BL806 Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 US Biomax 266 |
BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 |
US Biomax |
|
266€ |
|
Pub |
BN05014 Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011 US Biomax 160 |
BN05014 |
Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011 |
US Biomax |
|
160€ |
|
Pub |
BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
BO244a |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BR602 Breast tumor and normal tissue array, with TNM data, 25 cases 60 cores US Biomax 0 |
BR602 |
Breast tumor and normal tissue array, with TNM data, 25 cases 60 cores |
US Biomax |
|
0€ |
|
Pub |
BR727 Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011 US Biomax 231 |
BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011 |
US Biomax |
|
231€ |
|
Pub |
BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 US Biomax 456 |
BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 |
US Biomax |
|
456€ |
|
Pub |
BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores US Biomax 456 |
BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores |
US Biomax |
|
456€ |
|
Pub |
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 US Biomax 456 |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 |
US Biomax |
|
456€ |
|
Pub |
BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc US Biomax 429 |
BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc |
US Biomax |
|
429€ |
|
Pub |
CLC601 Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases 60 cores US Biomax 266 |
CLC601 |
Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases 60 cores |
US Biomax |
|
266€ |
|
Pub |
CO1002b Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002 US Biomax 321 |
CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002 |
US Biomax |
|
321€ |
|
Pub |
CO1501 Colon adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores US Biomax 321 |
CO1501 |
Colon adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores |
US Biomax |
|
321€ |
|
Pub |
CO2083 High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores US Biomax 456 |
CO2083 |
High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO2161 Colon cancer and normal colon tissue array, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
CO2161 |
Colon cancer and normal colon tissue array, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
CO244 Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
CO244 |
Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
CO487 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM and pathology grade, 16 cases 48 cores US Biomax 225 |
CO487 |
Colon adenocarcinoma with matched adjacent colon tissue array, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
225€ |
|
Pub |
CO702 Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115 US Biomax 266 |
CO702 |
Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115 |
US Biomax |
|
266€ |
|
Pub |
CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258 |
CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CR2081 High density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores US Biomax 456 |
CR2081 |
High density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR243 Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections slide US Biomax 160 |
CR243 |
Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections slide |
US Biomax |
|
160€ |
|
Pub |
CR244 Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 US Biomax 189 |
CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 |
US Biomax |
|
189€ |
|
Pub |
CR484 Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 225 |
CR484 |
Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
225€ |
|
Pub |
CR485 Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 231 |
CR485 |
Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
CR701 Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores US Biomax 266 |
CR701 |
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores |
US Biomax |
|
266€ |
|
Pub |
EM1021 Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases 102 cores US Biomax 314 |
EM1021 |
Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases 102 cores |
US Biomax |
|
314€ |
|
Pub |
EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296 |
EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
ES1501 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores US Biomax 321 |
ES1501 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores |
US Biomax |
|
321€ |
|
Pub |
ES2001 Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores US Biomax 516 |
ES2001 |
Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores |
US Biomax |
|
516€ |
|
Pub |
ES243 Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
ES243 |
Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
ES244 Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
ES483 Esophagus cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores US Biomax 189 |
ES483 |
Esophagus cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
ES781 Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111 US Biomax 266 |
ES781 |
Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111 |
US Biomax |
|
266€ |
|
Pub |
ES961 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores US Biomax 336 |
ES961 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores |
US Biomax |
|
336€ |
|
Pub |
FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a US Biomax 293 |
FCO401 |
Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a |
US Biomax |
|
293€ |
|
Pub |
FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 US Biomax 781 |
FCO401a |
Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 |
US Biomax |
|
781€ |
|
Pub |
FDA805-2 Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 US Biomax 278 |
FDA805-2 |
Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 |
US Biomax |
|
278€ |
|
Pub |
FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 |
FMC405 |
Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
FMC406 Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores US Biomax 167 |
FMC406 |
Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626 |
FMC406c |
Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331 |
FMC407 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
331€ |
|
Pub |
FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 |
FMC408 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
GL2083 Brain tumor and normal tissue array with pathology grade, 208 cases 208 cores US Biomax 456 |
GL2083 |
Brain tumor and normal tissue array with pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed US Biomax 90 |
GL241a |
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed US Biomax 296 |
GL803a |
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
HN483 Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 US Biomax 160 |
HN483 |
Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 |
US Biomax |
|
160€ |
|
Pub |
HN803 Head and neck squamous cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
HN803 |
Head and neck squamous cancer tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
IC00011b Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011 US Biomax 321 |
IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011 |
US Biomax |
|
321€ |
|
Pub |
KD2082 High density kidney cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores US Biomax 456 |
KD2082 |
High density kidney cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases 208 cores US Biomax 456 |
KD2084 |
Renal disease spectrum tissue array, with stage and TNM info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD243 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores US Biomax 189 |
KD243 |
Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
KD244 Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
KD484 Kidney cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
KD484 |
Kidney cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
KD485 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
KD485 |
Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
KD486 Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases 48 cores US Biomax 225 |
KD486 |
Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
225€ |
|
Pub |
LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores US Biomax 231 |
LC10010 |
Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LC10010a Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed US Biomax 296 |
LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
LC10012 Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 US Biomax 266 |
LC10012 |
Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 |
US Biomax |
|
266€ |
|
Pub |
LC10013 Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002 US Biomax 266 |
LC10013 |
Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002 |
US Biomax |
|
266€ |
|
Pub |
LC1501 Lung adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores US Biomax 321 |
LC1501 |
Lung adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores |
US Biomax |
|
321€ |
|
Pub |
LC2084 High density Lung cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores US Biomax 456 |
LC2084 |
High density Lung cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC2161 Lung cancer tissue array, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
LC2161 |
Lung cancer tissue array, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
LC243 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
LC243 |
Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
LC484 Lung cancer tissue array, including TNM and pathology grade, 48 cases 48 cores US Biomax 231 |
LC484 |
Lung cancer tissue array, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
LC485 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189 |
LC485 |
Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
LC486 Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases 48 cores US Biomax 188 |
LC486 |
Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
188€ |
|
Pub |
LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases 48 cores US Biomax 225 |
LC487 |
Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases 48 cores |
US Biomax |
|
225€ |
|
Pub |
LC727 Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores US Biomax 231 |
LC727 |
Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
LV1003 Liver cancer tissue array, with HBV infection information, including TNM and pathology grade, 50 cases 100 cores US Biomax 314 |
LV1003 |
Liver cancer tissue array, with HBV infection information, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
314€ |
|
Pub |
LV1501 Liver hepatocellular carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores US Biomax 321 |
LV1501 |
Liver hepatocellular carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores |
US Biomax |
|
321€ |
|
Pub |
LV2082 Liver cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores US Biomax 456 |
LV2082 |
Liver cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2161 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores US Biomax 456 |
LV2161 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
456€ |
|
Pub |
LV245 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189 |
LV245 |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
LV487 Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed US Biomax 185 |
LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
LV6161 High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores US Biomax 753 |
LV6161 |
High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
LV723 Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 US Biomax 231 |
LV723 |
Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 |
US Biomax |
|
231€ |
|
Pub |
LV8013 Hepatocellular carcinoma tissue array, including TNM, pathology grade, HBV and HCV infection information, 40 cases 80 cores US Biomax 321 |
LV8013 |
Hepatocellular carcinoma tissue array, including TNM, pathology grade, HBV and HCV infection information, 40 cases 80 cores |
US Biomax |
|
321€ |
|
Pub |
LV961 Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed US Biomax 228 |
LV961 |
Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
228€ |
|
Pub |
LY2081 Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases 208 cores US Biomax 456 |
LY2081 |
Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LY2084 Lymphoma tumor survey tissue array (4 of 5), 104 cases 208 cores US Biomax 456 |
LY2084 |
Lymphoma tumor survey tissue array (4 of 5), 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LY2085 Lymphoma tumor survey tissue array (5 of 5), 104 cases 208 cores US Biomax 456 |
LY2085 |
Lymphoma tumor survey tissue array (5 of 5), 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
MC5002 High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001 US Biomax 634 |
MC5002 |
High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001 |
US Biomax |
|
634€ |
|
Pub |
MC5003 High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002 US Biomax 634 |
MC5003 |
High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002 |
US Biomax |
|
634€ |
|
Pub |
MC542 Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541 US Biomax 160 |
MC542 |
Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541 |
US Biomax |
|
160€ |
|
Pub |
MC641 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 US Biomax 0 |
MC641 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 |
US Biomax |
|
0€ |
|
Pub |
MC8010 Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 278 |
MC8010 |
Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
278€ |
|
Pub |
ME1003 Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004 US Biomax 266 |
ME1003 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004 |
US Biomax |
|
266€ |
|
Pub |
ME1004a Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed US Biomax 296 |
ME1004a |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105 |
ME241a |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185 |
ME481a |
Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
ME483 Melanoma tissue array, including TNM and clinical stage, 48 cases 48 cores US Biomax 231 |
ME483 |
Melanoma tissue array, including TNM and clinical stage, 48 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296 |
ME803a |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 US Biomax 266 |
ME804 |
Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 |
US Biomax |
|
266€ |
|
Pub |
MS481a Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed US Biomax 296 |
MS481a |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
OV1502 Ovary adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores US Biomax 321 |
OV1502 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores |
US Biomax |
|
321€ |
|
Pub |
OV2082 Ovary cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores US Biomax 456 |
OV2082 |
Ovary cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2161 Ovary adenocarcinoma tissue array, including TNM and pathology grade, 216 cases 216 cores US Biomax 633 |
OV2161 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 216 cases 216 cores |
US Biomax |
|
633€ |
|
Pub |